4//SEC Filing
ARIAD PHARMACEUTICALS INC 4
Accession 0001127602-15-027701
CIK 0000884731operating
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 4:24 PM ET
Size
11.6 KB
Accession
0001127602-15-027701
Insider Transaction Report
Form 4
BERGER HARVEY J M D
DirectorChairman & CEO
Transactions
- Exercise/Conversion
Common Stock
2015-09-24+47,500→ 1,413,992 total - Award
Performance stock unit
2015-09-24+95,000→ 95,000 total→ Common Stock (95,000 underlying) - Exercise/Conversion
Performance stock unit
2015-09-24−47,500→ 47,500 total→ Common Stock (47,500 underlying)
Holdings
- 246,054(indirect: Daughter)
Common Stock
- 248,745(indirect: Daughter)
Common Stock
- 1,864,286(indirect: By LLC)
Common Stock
- 245,251(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]Shares were acquired upon vesting of performance stock units awarded on March 19, 2013.
- [F2]The reporting person is a managing member of this LLC.
- [F3]Each performance stock unit represents a right to receive one share of ARIAD common stock.
- [F4]The performance stock units vest as to 50% of the award on 9/24/2015 and 50% of the award on 9/24/2016.
Documents
Issuer
ARIAD PHARMACEUTICALS INC
CIK 0000884731
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000884731
Filing Metadata
- Form type
- 4
- Filed
- Sep 27, 8:00 PM ET
- Accepted
- Sep 28, 4:24 PM ET
- Size
- 11.6 KB